摘要:
An apparatus (2) for treating a cooling and rinsing fluid stemming from a soiled drilling fluid (15), including a first container (20) that collects the soiled drilling fluid (15), a second container (21) that is connected to a discharge line (38) for the treated cooling and rinsing fluid (36), a pressure switch (41) that is arranged in the discharge line (38) for purposes of measuring the pressure, and a control unit (40) for switching the treatment apparatus (2) over between a first mode of operation and at least one other mode of operation, whereby the treatment apparatus (2) can be switched over between the first and the at least one other mode of operation as a function of the pressure measured in the discharge line (38).
摘要:
A device and method for processing a cooling and rinsing liquid from a dirty liquid is disclosed. The device includes a first container, which is connected to a feed line for the dirty liquid, a second container, which is connected to a discharge line for the process cooling and rinsing liquid, and a filter element which is arranged in the second container. A connecting line connects the first and second containers and a bypass line connects the discharge line to the connecting line.
摘要:
A device for processing a cooling and flushing liquid from a dirty liquid is disclosed. The device includes a first container, which cooperates with a suction device for the dirty liquid and collects the suctioned dirty liquid, a second container, which cooperates with an overpressure device, and a filter element, which is arranged in the second container. The filter element is arranged in a direction of flow before the second container.
摘要:
The invention relates to the novel modifications B and C of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of the formula its use and pharmaceutical preparations comprising this crystal modifications.
摘要:
The invention relates to the novel modifications B and C of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of the formula its use and pharmaceutical preparations comprising this crystal modifications.
摘要:
A crystalline form of sertraline hydrochloride was found, referred to hereinafter as polymorphic form CSC2 having a dissolution rate which surprisingly will increase rate of absorption of a drug.Furthermore, different crystalline forms of sertraline hydrochloride alcohol solvates, crystalline forms of sertraline hydrochloride hydrates, referred to hereinafter as polymorphic form CSC1, a process for the preparation of the amorphous form of sertraline hydrochloride, and different processes for the preparation of polymorphic forms I, II, V, and T1 are disclosed.
摘要:
Novel crystalline forms of Fluvastatin sodium hydrates were found, referred to hereinafter as polymorphic Forms C, D, E and F. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms, a process for the preparation of highly crystalline Fluvastatin sodium Form A, and pharmaceutical compositions comprising the crystalline forms.
摘要:
The invention relates to the novel modifications B and C of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of the formula their use and pharmaceutical preparations comprising this crystal modifications.
摘要:
The present invention provides a hydrate of the 4,4′-di-triazinylamino-2,2′-di-sulfostilbene compound having the formula: in which M and M1 independently represent hydrogen, an alkaline-, an alkaline earth metal or ammonium, x is a number within the range of from 1 to 30, and the crystal form of the hydrate (I) being characterised by an X-ray diffraction pattern which is essentially as set out in the accompanying FIGS. 1 to 11; or a mixture containing one or more of the hydrates of the 4,4′-di-triazinylamino-2,2′-di-sulfostilbene compound having the formula (I); processes for the preparation of the new hydrates; and the use of the new hydrates for the preparation of concentrated aqueous formulations of fluorescent whitening agents.
摘要:
The present invention provides a hydrate of the 4,4'-di-triazinylamino-2,2'-di-sulfostilbene compound having the formula: ##STR1## in which M and M.sub.1 independently represent hydrogen, an alkaline-, an alkaline earth metal or ammonium, x is a number within the range of from 1 to 30, and the crystal form of the hydrate (I) being characterized by an X-ray diffraction pattern which is essentially as set out in the accompanying FIGS. 1 to 11; or a mixture containing one or more of the hydrates of the 4,4'-di-triazinylamino-2,2'-di-sulfostilbene compound having the formula (I); processes for the preparation of the new hydrates; and the use of the new hydrates for the preparation of concentrated aqueous formulations of fluorescent whitening agents.